Case Study: Accelerator
Accelerating world class research in Liverpool
A £11.5m loan to a world class life science hub in Liverpool marked a key milestone for the Chrysalis Fund. Not only was it the largest commitment made by the fund to date, but it also enabled a new chapter in the city’s history – the opportunity to lead the global fight in antibiotic resistance.
The new £25m Liverpool Life Sciences Accelerator co-locates the Royal Liverpool and Broadgreen University Hospitals NHS Trust, the Liverpool School of Tropical Medicine (LSTM) and a raft of relevant SMEs for large scale industrial collaboration and product development partnerships.